drugset / Trial / NCT00224263

Efficacy and Safety of Lingzhi in Patients With Early Parkinson's Disease

NCT00224263

Phase 2 Completed 360 enrolled Xuanwu Hospital, Beijing
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to determine whether Lingzhi (Ganoderma), a widely used traditional Chinese Medicine is effective and safe in the treatment of Parkinson's disease when combined use with L-dopa.

Timeline

Start
2005-09
Primary completion
Completion
2008-02

Drugs

EvaluationDrugModalityDoseRoute
Subject LingZhi Traditional medicine (herbal / TCM)

Indications